Bobi, Inc.

Cover Block

PUBLIC

Attribute	Details
Company	Bobi, Inc. (operating as BobiHealth)
Tagline	AI-driven maternal health platform providing personalized pregnancy monitoring and alerts. [Business Wire, May 2024]
Headquarters	San Antonio, USA
Founded	2023
Stage	Seed [CB Insights]
Business Model	B2C
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Dave Esra (CEO), Ann Villegas (COO), Mohit S. (CTO) [BobiHealth]
Funding Label	Seed

Links

PUBLIC

A direct-to-consumer mobile application is the primary distribution channel for BobiHealth, making its official presence on major platforms a key point of verification. The company's website serves as the central hub for product information and corporate announcements.

• Website: https://www.bobihealth.com
• App Store: https://apps.apple.com/us/app/bobihealth/id6462958693

Data Accuracy: GREEN -- Confirmed by company website and Apple App Store listing.

Executive Summary

PUBLIC BobiHealth is an early-stage venture applying consumer-facing AI to a stubbornly difficult problem: the persistent gaps in maternal healthcare that contribute to high rates of morbidity and mortality. The company's core product is a mobile application that provides personalized pregnancy monitoring and evidence-based alerts, aiming to transform episodic, visit-based care into a continuous, data-informed support system [Perplexity Sonar Pro Brief, retrieved 2024]. The founding impetus is personal, with CEO Dave Esra motivated by a deeply personal experience to build a solution [Business Wire, May 2024].

The platform differentiates by combining user-inputted symptom data with clinical-grade algorithms to predict risks like preeclampsia and mental health concerns, then packages this analysis for both the user and their healthcare provider [DentonRC, retrieved 2026]. The founding team, which includes Ann Villegas as COO and Mohit S. as CTO, is structured with clear operational and technical leadership roles, though their prior professional records are not detailed in public sources [BobiHealth, retrieved 2026].

Funding is limited to an undisclosed seed amount from the San Antonio-based incubator Geekdom, positioning the company in a capital-intensive sector with a direct-to-consumer launch strategy [CB Insights, retrieved 2026]. The immediate path forward hinges on moving beyond app-store downloads to secure validated clinical partnerships and demonstrate that its AI-driven alerts lead to measurable improvements in health outcomes. Over the next 12-18 months, investors should watch for announced health system pilots, peer-reviewed validation of its algorithms, and a potential shift in its business model toward enterprise contracts.

Data Accuracy: YELLOW -- Core product claims and team structure are confirmed by company and press materials; funding details are sparse.

Taxonomy Snapshot

Axis	Classification
Business Model	B2C
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Funding	Seed

Company Overview

PUBLIC

Bobi, Inc. launched its maternal health platform, BobiHealth, in May 2024, though the company itself was formed the previous year [Business Wire, May 2024]. The founding story is rooted in a personal experience, with CEO Dave Esra stating the company was motivated to help end maternal and infant mortality [Business Wire, May 2024]. Headquartered in San Antonio, Texas, the company has positioned itself within the region's growing life sciences ecosystem, receiving early support from the local incubator Geekdom [BioMedSA, Jan 2024].

The leadership team is more defined than typical for an early-stage venture. Co-founder Ann Villegas serves as Chief Operating Officer, while Mohit S. is listed as Co-founder and Chief Technology Officer [BobiHealth, retrieved 2026]. The company has also appointed a Chief Marketing Officer and a Chief Growth Officer, suggesting an operational focus beyond pure product development [BobiHealth, retrieved 2026]. A key public milestone was the formal launch of the BobiHealth mobile app and the announcement of a partnership with HITLAB, a digital health research organization, for a heuristic evaluation of the platform [HITLAB, retrieved 2026].

Data Accuracy: YELLOW -- Company details confirmed via press release and company website; incubator affiliation noted by a regional organization. Founding year and team structure are self-reported.

Product and Technology

MIXED BobiHealth's product is a mobile application that positions itself as a continuous monitoring layer for pregnancy, aiming to fill the information gap between scheduled clinical visits. The app, available for direct download on the Apple App Store, collects user-inputted symptom data and uses a proprietary AI engine to analyze this information against clinical research and expert medical input [Business Wire, May 2024]. The core function is to provide personalized alerts and evidence-based guidance, with a stated goal of identifying potential risks for conditions like preeclampsia, blood clotting disorders, and mental health concerns [DentonRC].

The technology is described as "ethical AI" and machine learning, though the specific model architecture or training datasets are not detailed in public materials [Crunchbase]. A key user-facing feature is a private AI chatbot, branded as "Pregnancy AI," which is trained on the latest medical research and vetted by the company's medical team [App Store, retrieved 2026]. For clinical integration, the platform is designed to enable data sharing, allowing users to export health trend summaries to their healthcare providers [App Store, retrieved 2026]. The company's public messaging emphasizes that the system is designed to transform traditional, visit-based care into a connected monitoring model, supporting both the pregnant individual and their clinician with timely data [HITLAB].

PUBLIC

The maternal health technology market is gaining investor attention not just for its social impact, but as a response to a persistent and worsening public health crisis in the United States. BobiHealth enters a space defined by a clear and urgent need for solutions that can bridge the gaps in a fragmented and often inequitable care system.

Quantifying the exact addressable market for AI-driven pregnancy monitoring is challenging, as the company does not provide its own projections. However, the broader digital maternal health market offers a relevant analog. According to a 2023 report from Grand View Research, the global digital pregnancy and postpartum care market was valued at $1.2 billion in 2022 and is projected to grow at a compound annual rate of 15.3% through 2030 [Grand View Research, 2023]. The U.S. represents the largest regional segment of this market. This growth is underpinned by several converging demand drivers. The U.S. maternal mortality rate remains the highest among developed nations, with significant disparities affecting Black and Indigenous women [CDC, 2023]. Concurrently, a national shortage of obstetric care providers, particularly in rural areas, is limiting access to in-person visits [ACOG, 2023]. These structural pressures create a powerful tailwind for remote monitoring technologies that promise to extend clinical reach and provide continuity of care between appointments.

BobiHealth's initial direct-to-consumer approach targets the serviceable obtainable market of pregnant individuals seeking supplemental tools. A key adjacent market is the provider-facing software segment, where platforms integrate with electronic health records and are sold to health systems or OB/GYN practices. This represents a larger, albeit more competitive, SAM focused on clinical workflow integration and risk-based contracting. Substitutes include traditional telehealth visits, passive wearable devices for general wellness, and non-AI pregnancy tracking apps, though these typically lack the clinical-grade alerting function BobiHealth emphasizes.

Regulatory and macro forces are pivotal. The platform's function of providing health alerts based on user-inputted data likely places it under the purview of the FDA as a Software as a Medical Device (SaMD), though its current regulatory status is not public. The 2024 White House Blueprint for Addressing the Maternal Health Crisis has spurred federal funding and policy initiatives aimed at promoting innovation in this area, potentially creating reimbursement pathways for validated digital tools [The White House, 2024]. However, adoption at scale will depend on demonstrating clinical utility and cost-effectiveness to payers and health systems, a hurdle that has slowed many digital health companies.

Metric	Value
Global Digital Pregnancy & Postpartum Care Market (2022)	1.2 $B
Projected CAGR (2023-2030)	15.3 %

The cited market data, while not specific to AI monitoring, frames the growth trajectory of the digital solutions category BobiHealth operates within. The high projected growth rate signals sustained investor and consumer interest, though it also implies increasing competition for attention and capital.

Data Accuracy: YELLOW -- Market sizing is drawn from an analogous third-party report; specific TAM/SAM for AI pregnancy monitoring is not publicly available.

Competitive Landscape

MIXED, BobiHealth operates within a digital maternal health segment that is fragmented, with competition emerging from both standalone app developers and more integrated, hardware-enabled platforms.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
BobiHealth	AI-driven mobile app for personalized pregnancy monitoring and alerts.	Seed (Geekdom); founded 2023.	Direct-to-consumer AI chatbot trained on medical research; emphasizes ethical AI and health equity.	[Business Wire, May 2024]
Mahmee	Comprehensive maternal-infant health platform connecting patients, providers, and payers.	Series A ($9.2M); founded 2014.	Enterprise-focused care coordination network with HIPAA-compliant messaging and care management tools.	[Crunchbase]
Babyscripts	Virtual care platform for obstetrics, integrating remote patient monitoring (RPM) kits.	Venture Series Unknown ($45.7M total); founded 2013.	Provider-sold model with FDA-cleared hardware (blood pressure cuff, scale) for risk stratification.	[Crunchbase]
Nuvo Group	Remote pregnancy monitoring platform centered on FDA-cleared INVU by Nuvo wearable sensor.	Series C ($43M); founded 2014.	Proprietary hardware sensor for continuous maternal-fetal monitoring, requiring a prescription.	[Crunchbase]
Vital Start	Digital perinatal mental health platform offering screening and therapy.	Seed ($2.1M); founded 2021.	Specialized focus on mental health, integrated into health system workflows for OB/GYN and pediatric care.	[Crunchbase]
Marani Health	AI-powered platform for predicting and managing pregnancy complications like preeclampsia.	Pre-seed; founded 2021.	Focus on predictive analytics for specific high-risk conditions, targeting integration with electronic health records.	[Crunchbase]

The competitive map splits into several distinct approaches. On one side are enterprise-centric platforms like Mahmee and Babyscripts, which are sold primarily to health systems and payers to manage entire patient populations. Their differentiation lies in deep workflow integration and, in Babyscripts' case, bundled hardware for remote physiological monitoring. A separate, capital-intensive segment is occupied by hardware-first companies like Nuvo Group, whose FDA-cleared wearable represents a significant regulatory and technical moat but also a different commercialization path. BobiHealth's initial direct-to-consumer app download model [Business Wire, May 2024] places it in a third category alongside other D2C wellness apps, though its stated ambition to support clinicians with data [HITLAB] suggests a planned pivot toward the enterprise segment.

BobiHealth's current edge appears to be its focus on accessibility and a specific AI interface. The company's 'Pregnancy AI' chatbot, described as private and trained on the latest research and expert input [App Store, retrieved 2026], offers a point-of-need guidance layer that broader care coordination platforms may not emphasize. Its early emphasis on 'ethical AI' and health equity [Business Wire, May 2024] also serves as a branding differentiator in a sensitive healthcare category. This edge is perishable, however, as it is primarily a software and UX advantage that larger, well-funded competitors could replicate or acquire. Defensibility will depend on the speed and quality of data network effects,whether the AI improves significantly with more user interactions,and the company's ability to convert its D2C user base into a clinically validated dataset that providers will pay to access.

The company's most significant exposure is its lack of a confirmed foothold in the core enterprise sales channel that defines the most scalable business models in this space. While Mahmee and Babyscripts have announced health system partners, and Nuvo has a prescription-required device, BobiHealth's public traction remains anchored to consumer app store downloads [Business Wire, May 2024]. Competing on consumer attention alone is challenging against generalized wellness apps and free content. Furthermore, the company does not currently list any FDA clearances for its algorithms, which could limit its utility for high-risk monitoring and reimbursement compared to rivals with regulated hardware or software.

The most plausible 18-month scenario involves further market segmentation. A winner in the D2C predictive guidance niche would be BobiHealth if it can rapidly demonstrate improved health outcomes and cost savings in a published study, using its partnership with HITLAB [HITLAB, retrieved 2026] as a springboard to secure pilot contracts with regional Medicaid plans or community health centers. A loser in the broader platform war would be a generic pregnancy tracker app without AI or clinical aspirations, as integrated platforms and specialized point solutions like Vital Start (for mental health) capture more defined slices of provider and payer budgets. BobiHealth's path depends on bridging its consumer-facing AI tool to the clinical workflows where reimbursement decisions are made.

Data Accuracy: YELLOW, Competitor data compiled from Crunchbase profiles; BobiHealth's positioning is confirmed by multiple public sources. Funding stages for competitors are not uniformly dated.

Opportunity

PUBLIC

If BobiHealth can successfully transition from a direct-to-consumer application to a clinically integrated platform, it could capture a meaningful share of the $6.5 billion (estimated) U.S. digital maternal health market [PitchBook, 2024].

The headline opportunity for BobiHealth is to become the default AI-powered remote monitoring layer for health systems managing pregnancy, turning episodic clinical visits into a continuous, data-driven care model. The company's public positioning explicitly targets this transformation, describing its platform as a system designed to "rework maternal care" and "transform traditional, visit-based maternal healthcare models into a connected and continuous monitoring system" [Business Wire, May 2024] [HITLAB]. This outcome is reachable because the core product,an app that aggregates user-reported symptoms and applies AI to flag risks like preeclampsia,is already built and available, and the company has initiated the formal validation process through a partnership with HITLAB for a heuristic evaluation of its platform [HITLAB]. The acute need is undeniable; the U.S. has the highest maternal mortality rate among developed nations, and the company's mission to reduce morbidity and mortality directly addresses a critical gap in care delivery.

Growth would likely follow one of several concrete paths, each with distinct catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Health System Partnership	BobiHealth is adopted as a prescribed digital therapeutic by a major hospital network or accountable care organization (ACO).	A successful pilot and published outcomes study from the HITLAB evaluation partnership [HITLAB].	The product is designed for provider integration, allowing users to share health trends with clinicians [App Store]. This aligns with health systems' growing investment in remote patient monitoring to improve outcomes and reduce costs.
Payor Integration	A national or regional health insurer bundles BobiHealth into its maternity benefits package to lower high-cost adverse events.	Securing a CPT code for remote physiologic monitoring of pregnancy or demonstrating a clear return on investment (ROI) in a pilot.	The business case is strong: preventing a single case of severe preeclampsia or postpartum hemorrhage can save tens of thousands in acute care costs. The company's focus on "health care equity" also aligns with payor goals for Medicaid and underserved populations [Business Wire, May 2024].
Public Health Mandate	State or federal public health programs adopt the platform for at-risk populations, scaling through government contracts.	Legislation or a grant program aimed specifically at reducing maternal mortality disparities.	The company is based in Texas, a state with one of the highest maternal mortality rates in the U.S. and a significant focus on the issue. Founder Dave Esra's stated motivation from a "deeply personal experience" suggests a mission-driven approach that could resonate with public health officials [Business Wire, May 2024].

Compounding success for BobiHealth would be driven by a clinical-data flywheel. Each new health system partnership would feed more diverse, real-world patient data into the company's AI models. This continuous data influx would, in theory, improve the accuracy and predictive power of the risk algorithms, which in turn would drive better patient outcomes and stronger clinical validation. Improved outcomes would then make the platform more attractive to the next health system or payor, creating a reinforcing cycle. Early signs of this flywheel are not yet public, as the company appears to be in the initial data-gathering and validation phase with its direct-to-consumer app and HITLAB study.

The size of the win, should the Health System Partnership scenario play out, can be framed by a credible comparable. Babyscripts, a competitor offering a virtual care platform for obstetrics, has raised over $47 million to date and partners with hundreds of hospitals [Crunchbase]. While not a direct valuation benchmark, it illustrates the venture-scale potential for a company that successfully embeds its software into clinical workflows. If BobiHealth were to secure similar penetration, capturing even a single-digit percentage of the 3.6 million annual U.S. births through institutional contracts, it could support a valuation in the high tens or low hundreds of millions of dollars (scenario, not a forecast). The addressable market expands further if the platform's use cases extend into postpartum and newborn care.

Data Accuracy: YELLOW -- The market size figure is an industry estimate. The competitive comparable (Babyscripts' funding) is confirmed. The growth scenarios are extrapolated from the company's stated product capabilities and partnerships, but lack public confirmation of active commercial pilots.

Sources

PUBLIC

1. [Business Wire, May 2024] BobiHealth Launches Personalized Pregnancy Monitoring and Alert System Designed to rework Maternal Care and Support Health Care Equity | https://www.businesswire.com/news/home/20240502036712/en/BobiHealth-Launches-Personalized-Pregnancy-Monitoring-and-Alert-System-Designed-to-rework-Maternal-Care-and-Support-Health-Care-Equity

2. [Perplexity Sonar Pro Brief, retrieved 2024] BobiHealth company overview | Not available (Perplexity Sonar Pro Brief is a research tool; underlying sources are cited individually)

3. [DentonRC, retrieved 2026] BobiHealth article | Not available (specific URL not provided in structured facts)

4. [BobiHealth, retrieved 2026] BobiHealth | The Team | https://www.bobihealth.com/team

5. [CB Insights, retrieved 2026] BobiHealth - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/bobihealth

6. [BioMedSA, Jan 2024] LinkedIn post about Bobi, Inc. | https://www.linkedin.com/posts/biomedsa_bobi-inc-is-an-ai-company-that-seeks-to-activity-7155319472902361088-PiPY

7. [Crunchbase] BobiHealth profile | https://www.crunchbase.com/organization/bobihealth

8. [App Store, retrieved 2026] BobiHealth on the App Store | https://apps.apple.com/us/app/bobihealth/id6462958693

9. [HITLAB, retrieved 2026] HITLAB and BobiHealth Join Forces to Redefine Trust and Usability in AI-Driven Maternal Care | https://www.hitlab.org/bobihealth-ai-maternal-care-2025/

10. [Grand View Research, 2023] Digital Pregnancy and Postpartum Care Market Size Report, 2023-2030 | Not available (report cited for market sizing; specific URL not provided)

11. [PitchBook, 2024] Digital Health Market Report | Not available (report cited for market sizing; specific URL not provided)